TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: gingival display
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drop seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: onset of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Achievement of primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of nausea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rescue antiemetic drug requirements
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of complete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction on the Beck Depression Inventory‐II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Color change of enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major curve correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risser sign improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of low back pain (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PHQ-9 total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infants' overall symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: night‐waking disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mothers' psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of narcotic pills consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Managing symptoms of arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-Adjusted Life Years (QALY) gained
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Complete nail clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to PASI 100
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean anesthetic time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Menstrual pain symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BDS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NHP sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Complete remission after 3 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of hairs removed by pull-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of anagen hair
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of telogen hairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of KIM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: long-term opioid utilization
Endpoint domain: Adverse events/effects
Primary endpoint: failure to rescue rates
Endpoint domain: Adverse events/effects
Primary endpoint: fewer verbal threats
Endpoint domain: Adverse events/effects
Primary endpoint: less violence overall
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative physical functioning (PF)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PTSS reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: KOOS-pain subdomain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptoms of mania
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CAVS at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving ketosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time of stone expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Increase in rotation movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional recovery after acute ischaemic stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased injury-related fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lip fullness augmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrinkle severity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adherence to completion of the questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Rates of amenorrhea
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of surgical wound dehiscence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction in CMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of injections
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Depression scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety scores reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median EFS
Endpoint domain: Mortality/survival
Primary endpoint: appetite measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of recurrent atrial fibrillation at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean peri-implant bone-loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: intubation clinical status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume reduction of leiomyoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to outpatient appointments
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Closure of postextraction sockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CES-D score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: VAS scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PGF2α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pilocarpine-induced angle widening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived helpfulness of weight management discussions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: child behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental perceptions of child difficulty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Derkay score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertion time to the splenic flexure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PTecc
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTecc/PTcon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AThams
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Physical and mental health (Short-Form 36 v2)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LSM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: improvements in liver steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hgb on PTDs 2 and 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hct and HBL on PTDs 1-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Preoperative transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: SC bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma tanezumab concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of lung recovery on chest CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Unintentional childhood injury
Endpoint domain: Adverse events/effects
Primary endpoint: Neurodevelopmental outcome at 2 years of age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in cancer pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child's post-TBI function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' TBI caregiving and community self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attendance to follow-up rehabilitation appointments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pulmonary Function Test (PFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean oxygen uptake (V̇O2) during HIIE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate (HR) during HIIE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of mNGS analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 4-km cycling TT performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre-TT bicarbonate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-TT blood lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean culture time of ISC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive outcomes by both methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of intraoperative sedatives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing damage and/or tinnitus risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Presenting visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean corneal thickness at the thinnest point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of keratoconus
Endpoint domain: Mortality/survival
Primary endpoint: diet-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CPRS‐48 total score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined risk of cardiovascular death or hospitalization for heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Completion of TME with negative margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Achieving best outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: No opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: Time to occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of coagulation factor XIII
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Freedom from local failure
Endpoint domain: Mortality/survival
Primary endpoint: Rate of primary efficacy outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total NTI time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mild epistaxis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular effects of empagliflozin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Negative emotion differentiation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients referred to behavioral health care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to negative nasopharyngeal swab and sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of virus shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertebral body height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertebral body angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiation exposure dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean HFNS problem rating score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Lutein levels in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHA levels in RBC membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of NRDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Need for neonatal ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ICD‐10 coded delirium and/or antipsychotic medication use
Endpoint domain: Adverse events/effects
Primary endpoint: Canine rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canine tipping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative NT-proBNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in depression symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in anxiety symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean root coverage values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aesthetical results
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effectiveness of postoperative acupuncture compared to preoperative acupuncture or meloxicam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Partial Mayo Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence-associated dermatitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: mean liner wear rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of osteolysis and aseptic loosening requiring revision surgery
Endpoint domain: Adverse events/effects
Primary endpoint: STRONGkids score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Slowing of gastric emptying (GE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Stimulation of gut hormone release (CCK, aGLP-1, PYY)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Median peak change of urinary neutrophil gelatinase‐associated lipocalin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of cystatin C increase ≥10% within 24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: recurrent viremia rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mortality of patients post PCI
Endpoint domain: Mortality/survival
Primary endpoint: time of myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time of vascular reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correct identification ratio of needle insertions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CT utilization rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: negative appendectomy rate
Endpoint domain: Adverse events/effects
Primary endpoint: 4-meter walk test completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycaemia frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Insulin sensitivity (Matsuda index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: QTcF-interval prolongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: subject analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent active
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent sedentary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: System usability scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in VAS for neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in foot problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Increase in foot care knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in foot care behavior scale mean scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient Assessment of Constipation Quality of Life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Foot posture improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minimum blood oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: average blood oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: average AHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased exudation
Endpoint domain: Adverse events/effects
Primary endpoint: non-fatal reinfarction
Endpoint domain: Adverse events/effects
Primary endpoint: Care aide involvement in formal communications
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: favourable functional outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total radiation dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of fluoroscopies performed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: duration of image guidance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: employee health-related behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy and Ready to Learn (HRL) prevalence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Predominantly prescriptive PADs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expert ratings of high feasibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Expert ratings of consistency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: jejunal SOD activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-AOC content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ratio of villus height-to-crypt depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Days on the waiting list
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance traveled for donors
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: freedom from progression (FFP)
Endpoint domain: Mortality/survival
Primary endpoint: Remnant-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retention of empirical knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Students' perceived increase in learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Emotional distress regarding simulation preparedness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression in King's stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of hysterectomy cases undertaken at low pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average rating of the visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes